- Meeting abstract
- Open Access
Asthma diagnosis and treatment – 1023. The implementation of asthma management guideline and the obstacle factors in Korea
© Jo et al; licensee BioMed Central Ltd. 2013
- Published: 23 April 2013
- Primary Care Physician
- Asthma Patient
- Asthma Control
- Oral Medication
There is gap between the guideline and real practice of asthma management. The implementation of asthma management guideline is essential to reduce the gap and for the qualified standard care. We evaluated the implementation of asthma management guideline and obstacle factors to the implementation in Korean physicians.
From March to April 2012, a total of 165 physicians in primary care, secondary and tertiary hospitals were enrolled. They filled in a questionnaire about their current practice on asthma: whether they followed the management guideline and if not, what might be the obstacle factors.
Thirty eight percent of the physicians were male and their mean age was 43 (± 8) years old. Ninety five percent of physicians had asthma patients in their clinics. Most of them (83.2%) knew about the asthma management guideline and 87.4% of them used the guideline on their asthma practice. Among the physicians, one hundred and twenty two (73.9%) were primary care physicians. 65.6% of the primary care physicians answered that they practiced according to the guideline for more than half of their patients. They reported difficulties in monitoring asthma control status. Only 26.2% of the primary care physicians prescribed inhaled corticosteroid (ICS) to most of their asthma patients, and the reasons that they do not prescribe ICS that much were physicians’ preference for oral medications and the concern about the possible refusal by the health insurance.
In primary care physicians, there was a huge gap between the management guideline and real practice. This study shows the necessity of education that ICS is the first-line choice in the treatment of asthma, and strongly suggests that the current health insurance policy should be improved for the better asthma care.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.